February 21, 2018 / 9:18 AM / 7 months ago

BRIEF-Merck And Viralytics Announce Acquisition Agreement

Feb 21 (Reuters) - Merck & Co Inc:

* MERCK AND VIRALYTICS ANNOUNCE ACQUISITION AGREEMENT, EXPANDING MERCK'S LEADING IMMUNO-ONCOLOGY PIPELINE

* MERCK - PROPOSED ACQUISITION VALUES THE TOTAL ISSUED SHARES IN VIRALYTICS AT APPROXIMATELY AUD 502 MILLION (USD 394 MILLION)

* MERCK - ON COMPLETION OF TRANSACTION, VIRALYTICS WILL BECOME A WHOLLY-OWNED SUBSIDIARY OF MERCK Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below